PET显像在2016 WHO中枢神经系统肿瘤分类下鉴别胶质瘤的价值
本研究纳入105例新诊断脑胶质瘤患者,按2016 WHO分类分析11C-蛋氨酸(MET)、11C-胆碱(CHO)和18F-氟脱氧葡萄糖(FDG)PET显像的肿瘤/正常皮质(T/N)比值与异柠檬酸脱氢酶(IDH)状态的关系,发现三种示踪剂在IDH野生型与突变型组间均有显著差异(p<0.001),提示PET有助于术前无创鉴别。
要点
- MET、CHO、FDG三种PET示踪剂在IDH野生型与突变型胶质瘤间T/N比值差异显著(p<0.001)。
- 在间变性星形细胞瘤中,IDH野生型组三种示踪剂T/N比值均显著高于突变型组(p<0.01)。
- 在胶质母细胞瘤中,IDH野生型组MET(p=0.034)和CHO(p=0.01)T/N比值显著更高,FDG无显著差异。
核心结论
- MET、CHO和FDG PET显像有助于术前根据2016 WHO分类鉴别胶质瘤,尤其对区分IDH野生型与突变型肿瘤具有价值。
研究设计与样本
- 回顾性研究纳入105例新诊断脑胶质瘤患者,包括6例IDH野生型弥漫性星形细胞瘤、6例IDH突变型弥漫性星形细胞瘤、7例IDH野生型间变性星形细胞瘤、24例IDH突变型间变性星形细胞瘤、26例IDH野生型胶质母细胞瘤、5例IDH突变型胶质母细胞瘤、19例少突胶质细胞瘤和12例间变性少突胶质细胞瘤。
主要发现
- 所有组织学分类中,IDH野生型与IDH突变型组间三种PET示踪剂的平均T/N比值均有显著差异(p<0.001)。
- 在27例三种示踪剂T/N比值均高于截断值的胶质瘤中,23例(85.2%)经ROC分析归为IDH野生型组。
- 弥漫性星形细胞瘤中,IDH野生型与突变型组间MET、CHO和FDG的T/N比值均无显著差异。
- 间变性星形细胞瘤中,IDH野生型组三种示踪剂平均T/N比值均显著高于IDH突变型组(p<0.01)。
- 胶质母细胞瘤中,IDH野生型组MET(p=0.034)和CHO(p=0.01)平均T/N比值显著高于IDH突变型组,FDG无显著差异。
关键数值与推荐
- 所有少突胶质细胞瘤和间变性少突胶质细胞瘤患者均具有IDH突变和1p/19q共缺失。
- T/N比值计算为肿瘤最大标准化摄取值(SUV)与正常皮质平均SUV之比。
临床怎么用
- 术前可考虑使用MET、CHO或FDG PET显像辅助鉴别胶质瘤的IDH状态,尤其适用于间变性星形细胞瘤和胶质母细胞瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. METHODS: In total, 105 patients with newly diagnosed cerebral gliomas (6 diffuse astrocytomas [DAs] with IDH-wt, 6 DAs with IDH-mut, 7 anaplastic astrocytomas [AAs] with IDH-wt, 24 AAs with IDH-mut, 26 glioblastomas [GBMs] with IDH-wt, 5 GBMs with IDH-mut, 19 oligodendrogliomas [ODs], and 12 anaplastic oligodendrogliomas [AOs]) were included. All OD and AO patients had both IDH-mut and 1p/19q codeletion. The maximum standardized uptake value (SUV) of the tumor/mean SUV of normal cortex (T/N) ratios for MET, CHO, and FDG were calculated, and the mean T/N ratios of DA, AA, and GBM with IDH-wt and IDH-mut were compared. The diagnostic accuracy for distinguishing gliomas with IDH-wt from those with IDH-mut was assessed using receiver operating characteristic (ROC) curve analysis of the mean T/N ratios for the 3 PET tracers. RESULTS: There were significant differences in the mean T/N ratios for all 3 PET tracers between the IDH-wt and IDH-mut groups of all histological classifications (p < 0.001). Among the 27 gliomas with mean T/N ratios higher than the cutoff values for all 3 PET tracers, 23 (85.2%) were classified into the IDH-wt group using ROC analysis. In DA, there were no significant differences in the T/N ratios for MET, CHO, and FDG between the IDH-wt and IDH-mut groups. In AA, the mean T/N ratios of all 3 PET tracers in the IDH-wt group were significantly higher than those in the IDH-mut group (p < 0.01). In GBM, the mean T/N ratio in the IDH-wt group was significantly higher than that in the IDH-mut group for both MET (p = 0.034) and CHO (p = 0.01). However, there was no significant difference in the ratio for FDG. CONCLUSIONS: PET imaging using MET, CHO, and FDG was suggested to be informative for preoperatively differentiating gliomas according to the 2016 WHO classification, particularly for differentiating IDH-wt and IDH-mut tumors.
引用
- Takei H, Shinoda J, Ikuta S, et al. Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system. J Neurosurg. 2019. PMID: 31419796. doi:10.3171/2019.5.JNS19780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。